Soluble urokinase receptor: risk factor and therapeutic target in kidney diseases

Medicine Grand Rounds

Wednesday, October 2, 2019 at 7:45 AM


This grand round has already taken place.


Lecture Hall 2 - Stony Brook, NY
October 2nd, 2019
1.00 AMA PRA Category 1 Credit Hours

Description

Soluble urokinase receptor: risk factor and therapeutic target in kidney diseases

Dates and Times

Start: 10/2/2019 7:45 AM
End: 10/2/2019 8:45 AM

Objectives

1) Understand the immunological connection of the immune system and the kidney

2) Learn how suPAR contributes to chronic kidney diseases

3) Learn how suPAR contributes to acute kidney injury

Speakers

  • Dr. Jochen Reiser
    • Soluble urokinase receptor: risk factor and therapeutic target in kidney diseases

Location

Lecture Hall 2
101 Nicolls Road
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222